Genchi, V. A.
Palma, G.
Sorice, G. P.
D’Oria, R.
Caccioppoli, C.
Marrano, N.
Biondi, G.
Caruso, I.
Cignarelli, A.
Natalicchio, A.
Laviola, L.
Giorgino, F. http://orcid.org/0000-0001-7372-2678
Perrini, S.
Funding for this research was provided by:
UniversitĂ degli Studi di Bari Aldo Moro
Article History
Received: 3 January 2023
Accepted: 29 May 2023
First Online: 28 June 2023
Declarations
:
: V.A.G., G.P, G.P.S, R.D., C.C., N.M., G.B., I.C., A.C. and A.N. declare no conflict of interest. L.L. has received consultant fees and speaker fees from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, MOVI, Medtronic, Menarini, Novo Nordisk, Roche Diabetes Care, Sanofi and Terumo. F.G. has provided advisory services to AstraZeneca, Eli Lilly, Novo Nordisk, Roche Diabetes Care, and Sanofi, received speaker fees and served as a consultant for Boehringer Ingelheim, Lifescan, Merck Sharp & Dohme, Sanofi, AstraZeneca, Medimmune, Roche Diabetes Care and Medtronic, and received research support from Eli Lilly and Roche Diabetes Care. S.P. has received consultant fees and speaker fees from Eli Lilly and Novo Nordisk.
: Not applicable.
: Not applicable.